Original Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2012; 18(43): 6226-6234
Published online Nov 21, 2012. doi: 10.3748/wjg.v18.i43.6226
Figure 4
Figure 4 Effects of erlotinib on epidermal growth factor receptor signal transduction in BxPC-3 and Capan-1 cells. Serum-starved pancreatic cancer cells were preincubated with erlotinib at 1 μmol/L for 4 h, as indicated, before they were stimulated with 10 ng/mL epidermal growth factor (EGF) for the indicated times. Protein extracts from equal amounts of cells were subjected to Western blot analysis. Phospho-epidermal growth factor receptor (pEGFR), phospho-protein kinase B (pAKT), phospho-extracellular signal-regulated kinase 1/2 (pERK1/2), their respective total proteins and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were detected using fluorescein (IRDye®)-labeled secondary antibodies. One representative Western blot is shown. For mean values of independent experiments, please refer to Figure 5. AKT: Protein kinase B; ERK: Extracellular signal-regulated kinase; EGFR: Epidermal growth factor receptor.